Nobody Warns You About the Total Cost
When patients first hear that medical cannabis is legal in the UK, the next question is almost always: how much does it cost? The answer, unfortunately, is rarely straightforward. Clinic websites show consultation fees. Pharmacy listings show product prices. But the total annual cost — the number patients actually pay — is rarely published upfront. This guide breaks it down honestly.
The Cost Breakdown for UK Medical Cannabis Patients
Initial Consultation: £50–£200
Your first appointment with a specialist clinic involves a detailed medical assessment. The cost varies significantly between providers: some newer digital-first services charge as little as £50, while established clinical practices charge up to £200. Be cautious of very cheap consultations — if the fee seems designed to get you in the door, check what follow-up care costs.
Prescription Cost: £80–£350 per month
This is the biggest recurring expense. UK medical cannabis products — oils, flowers, capsules, lozenges — are priced significantly higher than recreational cannabis in countries where it is legal. A standard prescription for cannabis flower (typically 10–30g per month) costs between £100 and £250. Oil-based products vary widely by concentration and volume.
Follow-up Appointments: £50–£150 every 1–3 months
Legitimate clinics require regular check-ins to monitor your treatment and adjust your prescription. These are not optional — they are part of responsible prescribing. Expect to pay £50–£150 per follow-up, typically every 1–3 months depending on your clinic and condition.
Pharmacy Dispensing: Free to £15
Most UK cannabis pharmacies offer free delivery. Some charge a small dispensing fee. This is usually a minor cost but worth confirming upfront.
What Does a Year of Medical Cannabis Actually Cost?
| Item | Low | High |
|---|---|---|
| Initial consultation | £50 | £200 |
| Prescription (12 months) | £960 | £4,200 |
| Follow-ups (4 per year) | £200 | £600 |
| Total annual cost | £1,210 | £5,000 |
Why Is It So Expensive?
Several factors drive the high cost of medical cannabis in the UK:
- No NHS subsidy — unlike most prescription medicines, medical cannabis is not on the NHS prescription formulary for most conditions. You pay full private cost.
- Import costs — most UK medical cannabis is imported from Canada, Germany, the Netherlands and Portugal. Import duties and supply chain costs are passed on.
- Limited competition — the UK licensing regime limits the number of approved suppliers, reducing price pressure.
- MHRA regulation — compliance costs for licensed producers are significant.
Is It Worth It?
This is the question only you can answer, but the evidence suggests that for many patients, the answer is yes. Project Twenty21, the UK’s largest real-world evidence study, found that 74% of participants reported improved quality of life after six months on medical cannabis, with significant reductions in pain, anxiety, sleep problems and depression scores.
For patients who have tried multiple conventional treatments without success, medical cannabis can represent a genuine turning point — even at private prices. Our dosing guide for chronic pain and sleep dosing guide help you understand what effective treatment actually looks like.
How to Reduce the Cost
- Compare clinics carefully — our clinic comparison guide covers fees transparently
- Ask about price-matching or loyalty schemes — some clinics offer reduced follow-up rates for long-term patients
- Optimise your prescription — work with your doctor to find the lowest effective dose; this reduces monthly costs significantly
- Check for insurance changes — some private health insurers are beginning to cover prescribed cannabis. Check your policy.
- Charitable support — organisations including the Medical Cannabis Clinician Society and several patient groups offer support for patients who cannot afford treatment
The Future of Costs
The outlook for costs in 2026–2028 is cautiously optimistic. UK domestic cultivation licences are expanding. Competition between clinics is intensifying. And as the evidence base grows, pressure on NHS commissioners to offer some form of funding pathway is increasing. For now, private costs remain the reality — but they are trending downward from the peaks of 2020–2022.
For everything you need to know about navigating the UK medical cannabis system, start with our complete UK patient guide.